Skip to main content
Ross Liao, MD, Urology, Cleveland, OH

RossLiaoMD

Urology Cleveland, OH

Minimally Invasive Surgery, Stone Disease, Surgical Oncology

Urology Resident at Cleveland Clinic

Dr. Liao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Liao's full profile

Already have an account?

  • Office

    Cleveland Clinic - Glickman Urological & Kidney Institute
    9500 Euclid Ave., Q10
    Cleveland, OH 44195

Summary

  • Dr. Ross Liao graduated summa cum laude from Johns Hopkins University with a B.S. in Molecular and Cellular Biology. He obtained his M.D. from the prestigious Johns Hopkins School of Medicine. He is currently completing urology residency at Cleveland Clinic, one of the nation's most well-regarded and largest urology department. His clinical interests span the breadth of urology and include minimally invasive robotic surgery, stone disease, surgical oncology, and GU reconstructive/prosthetic surgery. Dr. Liao has more than 10 scientific publications in prestigious urologic journals including the Journal of Urology. He fluently speaks both English and Mandarin Chinese.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Urology, 2020 - 2026
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2020
  • Johns Hopkins University
    Johns Hopkins UniversityBS, Molecular and Cellular Biology, Summa Cum Laude, 2011 - 2015

Awards, Honors, & Recognition

  • Lester Persky Urologic Research Award Johns Hopkins Brady Urological Institute, 2016-2018

Publications & Presentations

PubMed

Journal Articles

  • Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From Diagnosis to Novel Therapeutic Horizons  
    Ross S. Liao, Hui Ting Ruan, Albert Jang, Melissa Huynh, Rosa Nadal Rios, Jean H. Hoffman-Censits, Shuanzeng Wei, Omar Y. Mian, Pedro C. Barata, ASCO Ed Book, 1/4/2024
  • Contemporary Management of Bulbar Urethral Strictures  
    Ross S. Liao, MD, Erica Stern, BS, James E. Wright, MD, Andrew J. Cohen, MD, Reviews in Urology, 4/10/2021
  • Impact of Sex on Response to Neoadjuvant Chemotherapy in Patients with Upper-tract Urothelial Cancer  
    David D’Andrea, Beat Foerster, Surena F. Matin, Ja H. Ku, Tim Muilwijk, Leonardo L. Monteiro, Ross Liao, Firas Petros, Philippe E. Spiess, Trinity J. Bivalacqua, Kees ..., European Urology Open Science

Press Mentions

  • AUA 2018: Incidence of Lower Pathologic Stage in Patients Treated with Neoadjuvant Chemotherapy for High-Risk Upper Tract Urothelial Carcinoma
    AUA 2018: Incidence of Lower Pathologic Stage in Patients Treated with Neoadjuvant Chemotherapy for High-Risk Upper Tract Urothelial CarcinomaMay 18th, 2018

Professional Memberships

  • American Urological Association
    Member

Other Languages

  • Chinese (Mandarin), Taiwanese